Skip to content

Clinical trials

Recruiting Phase 2/3 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Recruiting Country / region: South Korea Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20201
20211
20223
20233
20246
202515
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
AbbVie4
Merck Sharp & Dohme LLC3
Eikon Therapeutics2
Janssen Research & Development, LLC2
Pfizer2
Washington University School of Medicine2
ACADIA Pharmaceuticals Inc.1
Bicara Therapeutics1
BioMarin Pharmaceutical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Lung Neoplasms3
Neoplasm Metastasis3
Alzheimer Disease2
Dementia2
Pancreatic Neoplasms2
Achondroplasia1
Adenoma, Islet Cell1
Anorexia1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.